Neurogene Inc. (NASDAQ:NGNE) Receives $46.20 Consensus PT from Brokerages
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has earned an average rating of “Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. […]
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has earned an average rating of “Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. […]
